These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 26774944

  • 1. A new modified wetting test and an alternative disintegration test for orally disintegrating tablets.
    Hooper P, Lasher J, Alexander KS, Baki G.
    J Pharm Biomed Anal; 2016 Feb 20; 120():391-6. PubMed ID: 26774944
    [Abstract] [Full Text] [Related]

  • 2. Further improvement of orally disintegrating tablets using micronized ethylcellulose.
    Okuda Y, Irisawa Y, Okimoto K, Osawa T, Yamashita S.
    Int J Pharm; 2012 Feb 28; 423(2):351-9. PubMed ID: 22138608
    [Abstract] [Full Text] [Related]

  • 3. Comparative Study Between Different Ready-Made Orally Disintegrating Platforms for the Formulation of Sumatriptan Succinate Sublingual Tablets.
    Tayel SA, El Nabarawi MA, Amin MM, AbouGhaly MH.
    AAPS PharmSciTech; 2017 Feb 28; 18(2):410-423. PubMed ID: 27038484
    [Abstract] [Full Text] [Related]

  • 4. Development of a new disintegration method for orally disintegrating tablets.
    Kakutani R, Muro H, Makino T.
    Chem Pharm Bull (Tokyo); 2010 Jul 28; 58(7):885-90. PubMed ID: 20606331
    [Abstract] [Full Text] [Related]

  • 5. Formulation studies for mirtazapine orally disintegrating tablets.
    Yıldız S, Aytekin E, Yavuz B, Bozdağ Pehlivan S, Ünlü N.
    Drug Dev Ind Pharm; 2016 Jul 28; 42(6):1008-17. PubMed ID: 26530146
    [Abstract] [Full Text] [Related]

  • 6. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S, Iwao Y, Kimura S, Itai S.
    Int J Pharm; 2011 Sep 15; 416(1):252-9. PubMed ID: 21763765
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus.
    Brniak W, Jachowicz R, Krupa A, Skorka T, Niwinski K.
    Pharm Dev Technol; 2013 Sep 15; 18(2):464-74. PubMed ID: 22881600
    [Abstract] [Full Text] [Related]

  • 8. Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics.
    Rawas-Qalaji MM, Simons FE, Simons KJ.
    AAPS PharmSciTech; 2006 Apr 28; 7(2):E41. PubMed ID: 16796358
    [Abstract] [Full Text] [Related]

  • 9. Conceptualisation, Development, Fabrication and In Vivo Validation of a Novel Disintegration Tester for Orally Disintegrating Tablets.
    Koner JS, Rajabi-Siahboomi AR, Missaghi S, Kirby D, Perrie Y, Ahmed J, Mohammed AR.
    Sci Rep; 2019 Aug 28; 9(1):12467. PubMed ID: 31462654
    [Abstract] [Full Text] [Related]

  • 10. Development and optimization of dextromethorphan hydrobromide oral disintegrating tablets: effect of formulation and process variables.
    Mostafa HF, Ibrahim MA, Sakr A.
    Pharm Dev Technol; 2013 Aug 28; 18(2):454-63. PubMed ID: 22881389
    [Abstract] [Full Text] [Related]

  • 11. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y, Irisawa Y, Okimoto K, Osawa T, Yamashita S.
    Int J Pharm; 2009 Dec 01; 382(1-2):80-7. PubMed ID: 19686825
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dissolution testing of orally disintegrating tablets.
    Kraemer J, Gajendran J, Guillot A, Schichtel J, Tuereli A.
    J Pharm Pharmacol; 2012 Jul 01; 64(7):911-8. PubMed ID: 22686339
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation about wettability, water absorption or swelling of excipients through various methods and the correlation between these parameters and tablet disintegration.
    Yang B, Wei C, Yang Y, Wang Q, Li S.
    Drug Dev Ind Pharm; 2018 Sep 01; 44(9):1417-1425. PubMed ID: 29557692
    [Abstract] [Full Text] [Related]

  • 16. [Establishment of a Novel Method to Evaluate Water Permeation Rates by Combining the Dynamic Contact Angle and Thermographic Approach: Significance of Disintegration Properties of Orally Disintegrating Tablets].
    Suzuki T, Kurano T, Kanazawa T, Suzuki N.
    Yakugaku Zasshi; 2020 Sep 01; 140(8):1071-1080. PubMed ID: 32741865
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical disintegration time of orally disintegrating tablets clinically available in Japan in healthy volunteers.
    Yoshita T, Uchida S, Namiki N.
    Biol Pharm Bull; 2013 Sep 01; 36(9):1488-93. PubMed ID: 23995661
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of the disintegration properties of commercial famotidine 20 mg orally disintegrating tablets using a simple new test and human sensory test.
    Harada T, Narazaki R, Nagira S, Ohwaki T, Aoki S, Iwamoto K.
    Chem Pharm Bull (Tokyo); 2006 Aug 01; 54(8):1072-5. PubMed ID: 16880646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.